Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Quantum Computing Inc (QUBT) Price & Performance

Cassava Sciences IncTrade
Quantum Computing IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Quantum Computing Inc — how do they compare? Cassava Sciences Inc trades at $0.95 (market cap $47.75M), while Quantum Computing Inc trades at $8.9 (market cap $2.03B). The key difference: Quantum Computing Inc is far larger — about 42.5× Cassava Sciences Inc's market cap, and Quantum Computing Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

FLNAQUBT
Market Cap
$47.75M$2.03B
Sector
HealthTechnology
52-Week High
$4.64$24.62
52-Week Low
$0.87$6.31
Enterprise Value
-$34.93M$1.09B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.

Quantum Computing Inc

Quantum Computing Inc. (QUBT) trades at $9.07, up 1.57% with bearish technical signals despite recent revenue growth. The company reported Q2 2026 revenue of $5.6 million, a significant increase from prior periods, though profitability remains challenged with negative margins. Analyst consensus is bullish with a $18.50 price target, while institutional interest grows with recent purchases by Amundi and Bank of New York Mellon.

QUBT presents high-risk, high-reward potential with strong revenue growth from photonics sales but faces execution risks and negative profitability. The stock's 75% buy rating from analysts suggests upside potential, though investors must weigh the speculative nature against substantial cash reserves and expanding manufacturing capabilities.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Quantum Computing Inc

Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.

Read more on QUBT